Adjustments for Non-Cash Items (USD)

Stock-Based Compensation (USD)

Changes in Working Capital (USD)

Capital Expenditures (CapEx) (USD)

Proceeds from / Repayments of Debt (USD)

Share Repurchases (USD)

Dividend Payments (USD)

Net Change in Cash (USD)

60e0ed193b5d2cc79df86f9dd15d62b6394fd1a628ddc4d555dbd87e0499b18d

Total Revenue (USD)

Cost of Goods Sold (COGS) (USD)

Selling, General, and Administrative Expenses (SG&A) (USD)

Research and Development (R&D) (USD)

Depreciation and Amortization (D&A) (USD)

Interest Expense (USD)

Operating Income (EBIT) (USD)

Net Income (USD)

Earnings Per Share (EPS) - Basic (USD/share)

Earnings Per Share (EPS) - Diluted (USD/share)

a58f9a1f479e44172cd3336e7b53e585049b85c2e38de4b0871c4d6e38ba11da

Current Assets (USD)

Cash and Cash Equivalents (USD)

Accounts Receivable (USD)

Inventory (USD)

Non-Current Assets (USD)

Property, Plant, and Equipment (PP&E) (USD)

Goodwill (USD)

Intangible Assets (USD)

Current Liabilities (USD)

Accounts Payable (USD)

Short-term Debt (USD)

Accrued Expenses (USD)

Non-Current Liabilities (USD)

Long-term Debt (USD)

Lease Liabilities (USD)

Deferred Tax Liabilities (USD)

Shareholders' Equity (USD)

Retained Earnings (USD)

Common Stock (USD)

Additional Paid-in Capital (USD)

b094d96beb5281a1fac2b00f3a7ac580a9f7591eacb0d6364bf64aa145deae7f

Number of patients in completed SLK-related trials (patients)

4e9aed40ab48f0ddbc1520101ea1d1c43c66cb2738dcb62b31343ef530af9144

Cash and cash equivalents (USD)

Short-term marketable debt securities (USD)

Other receivables (USD)

Prepaid expenses - current (USD)

Total current assets (USD)

Operating lease right-of-use assets (USD)

Property and equipment, net (USD)

Prepaid expenses - non-current (USD)

Total non-current assets (USD)

Total assets (USD)

Trade and other payables (USD)

Short-term portion of operating lease liabilities (USD)

Accrued expenses and other current liabilities (USD)

Total current liabilities (USD)

Long-term portion of operating lease liabilities (USD)

Pension liability (USD)

Total non-current liabilities (USD)

Total liabilities (USD)

Class A Ordinary Shares (USD)

Class C Ordinary Shares (USD)

Additional paid-in capital (USD)

Accumulated deficit (USD)

Accumulated other comprehensive income (USD)

Total shareholders’ equity (USD)

Noncontrolling interests (USD)

Total equity (USD)

Total liabilities and equity (USD)

5cba604b0df25b9ef6843404e46e5537bc863d1bdb5802f0913e8fb091de524d

MoonLake Immunotherapeutics (MLTX)

Financials